Faculty Bibliography

Try a new search

Format these results:

Searched for:

in-biosketch:true

person:segevd01

Total Results:

1119

American journal of transplantation. 2022:22:58-59.DOI:

Racial and Ethnic Disparities in Post-KAS Kidney Transplantation [Meeting Abstract]

Zeiser, Laura; Charnaya, Olga; Yisar, Dolev; Goldberg, Aviva; Segev, Dorry; Massie, Allan; Garonzik-Wang, Jacqueline; Verghese, Priya
ISI:000739470700112
ISSN: 1600-6135
CID: 5133612
American journal of transplantation. 2022:22:60-60.DOI:

Effect of Immunosuppression Withdrawal after Graft Failure on Re-Kidney Transplantation Outcomes [Meeting Abstract]

Ahn, JiYoon; Sandal, Shaifali; Bae, Sunjae; Segev, Dorry; McAdams-DeMarco, Mara
ISI:000739470700116
ISSN: 1600-6135
CID: 5133622
American journal of transplantation. 2022:22:62-63.DOI:

YYY Transplant Centers That Assesses Frailty as Part of Clinical Practice Have Better Outcomes [Meeting Abstract]

Chen, Xiaomeng; Liu, Yi; Chu, Nadia; King, Elizabeth; Walston, Jeremy; Kobashigawa, Jon; Dadhania, Darshana; Segev, Dorry; McAdams-DeMarco, Mara
ISI:000739470700119
ISSN: 1600-6135
CID: 5133632
American journal of transplantation. 2022:22:70-71.DOI:

Perception of Transplant Surgery and the Pursuit of a Career in Transplant Surgery Among US General Surgery Residents [Meeting Abstract]

Loseth, Caitlin; Qin, Caroline; Zeiser, Laura; Segev, Dorry; Dageforde, Leigh Anne; Watkins, Anthony; Collins, Kelly; Glorioso, Jaime; Quillin, R. Cutler, III; Garonzik-Wang, Jacqueline; Tevar, Amit
ISI:000739470700138
ISSN: 1600-6135
CID: 5133652
American journal of transplantation. 2022:22:74-74.DOI:

Facilitating Education and Advocacy Training to Expand Live Donor Kidney Transplantation in the setting of the COVID-19 pandemic: Experience with the ENGAGE Multi-center Trial [Meeting Abstract]

Mitchell, Jonathan; Lopez, Julia; Nijhar, Kieranjeet; Zeiser, Laura Bowles; Chiang, Teresa; King, Elizabeth; Segev, Dorry; Cameron, Andrew
ISI:000739470700146
ISSN: 1600-6135
CID: 5133662
American journal of transplantation. 2022:22:76-76.DOI:

Characterizing the early impact of the Kidney Accelerated Placement Project on hard-to-place kidneys [Meeting Abstract]

Motter, Jennifer; Kernodle, Amber; Gentry, Sommer; Levan, Macey; Wood, Nicholas; Segev, Dorry; Garonzik-Wang, Jacqueline; Massie, Allan
ISI:000739470700152
ISSN: 1600-6135
CID: 5133672
American journal of transplantation. 2022:22:83-84.DOI:

Long-term Frailty Trajectories After Kidney Transplantation [Meeting Abstract]

Ruck, Jessica; Chu, Nadia; Chen, Xiaomeng; Bandeen-Roche, Karen; Norman, Silas; Segev, Dorry; McAdams-DeMarco, Mara
ISI:000739470700169
ISSN: 1600-6135
CID: 5133682
American journal of transplantation. 2022:22:97-97.DOI:

Increased Logistical Complexity In Circle-Based Organ Allocation [Meeting Abstract]

Wood, Nicholas; VanDerwerken, Douglas; Segev, Dorry; Gentry, Sommer
ISI:000739470700198
ISSN: 1600-6135
CID: 5133692
American journal of transplantation. 2022:22:101-101.DOI:

Opportunities for Improved Efficiency in Kidney Distribution: A Comparison of Center-Specified UNet Donor Criteria to Actual Kidney Acceptance Practices [Meeting Abstract]

Zeiser, Laura; Gentry, Sommer; Segev, Dorry; Massie, Allan
ISI:000739470700207
ISSN: 1600-6135
CID: 5133702
BMC cancer. 2021:21(1).DOI: 10.1186/s12885-021-09097-5

Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma

Greenberg, Ross S; Ruddy, Jake A; Boyarsky, Brian J; Werbel, William A; Garonzik-Wang, Jacqueline M; Segev, Dorry L; Imus, Philip H
BACKGROUND:Patients with multiple myeloma (MM) were excluded from the original SARS-CoV-2 mRNA vaccine trials, which may influence vaccine hesitancy in this population. We prospectively characterized the safety and immunogenicity of two-dose SARS-CoV-2 mRNA vaccination in 44 patients with MM, who underwent vaccination from 12/17/2020 to 3/18/2021. RESULTS:Rates adverse reactions were low and consistent with those documented in vaccine trials. Among those on MM therapy, 93% developed detectable anti-receptor binding domain (RBD) antibodies after dose 2, while 94% of patients not on MM therapy seroconverted. CONCLUSIONS:Two-dose SARS-CoV-2 mRNA vaccination is mildly reactogenic and leads to high rates of seroconversion in patients with MM. These findings can provide reassurance to MM patients who are hesitant to receive SARS-CoV-2 mRNA vaccines.
PMCID:8711688
PMID: 34961488
ISSN: 1471-2407
CID: 5127852